Moderna CEO says data for Omicron-specific shot likely available in March | Inquirer News

Moderna CEO says data for Omicron-specific shot likely available in March

/ 10:28 PM January 17, 2022

Moderna's coronavirus disease (COVID-19) vaccine at the Bathgate Post Office vaccination facility in the Bronx, New ork

Nurse Ellen Quinones prepares a dose of the Moderna’s coronavirus disease (COVID-19) vaccine at the Bathgate Post Office vaccination facility in the Bronx, in New York, US, Jan. 10, 2021. (Kevin Hagen/Pool via REUTERS)

Moderna Inc.’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

“The vaccine is being finished … it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps,” Bancel said at the World Economic Forum’s virtual Davos Agenda conference.

Article continues after this advertisement

Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.

FEATURED STORIES

Bancel said the best-case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries.

“Our goal is to be able to have a single annual booster so that we don’t have compliance issues where people don’t want to get two to three shots a winter.”

Article continues after this advertisement

Many countries are already offering a third dose of a COVID-19 vaccine to their citizens, especially to older individuals and those who are immunocompromised, while Israel has started offering its citizens a fourth dose.

Article continues after this advertisement

Earlier in January, Moderna’s CEO said people may need a fourth shot in the fall of 2022 as the efficacy of boosters against COVID-19 was likely to decline over the next few months.

Article continues after this advertisement

However, booster programs have met with skepticism from some disease experts over whether, and how widely, additional doses should become available, including the European Union’s drug regulator, which has expressed doubts about the need for a fourth booster dose.

Speaking at the same event, top U.S. infectious disease expert Anthony Fauci said there was no evidence that repeat booster doses would overwhelm the immune system.

Article continues after this advertisement

“Giving boosters at different times, there is really no evidence that’s going to hinder (immune response).”

Fauci said the goal should be to have a booster that induces a response against multiple potential variants.

ATM
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.